Cargando…
Corrigendum to “PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis” [EBioMedicine 40 (2019) 290-304]
| Autores principales: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340498/ https://www.ncbi.nlm.nih.gov/pubmed/35914489 http://dx.doi.org/10.1016/j.ebiom.2022.104194 |
| _version_ | 1784760418140422144 |
|---|---|
| author | Rodriguez-Aguayo, Cristian Bayraktar, Emine Ivan, Cristina Aslan, Burcu Mai, Junhua He, Guangan Mangala, Lingegowda S. Jiang, Dahai Nagaraja, Archana S. Ozpolat, Bulent Chavez-Reyes, Arturo Ferrari, Mauro Mitra, Rahul Siddik, Zahid H. Shen, Haifa Yang, Xianbin Sood, Anil K. Lopez-Berestein, Gabriel |
| author_facet | Rodriguez-Aguayo, Cristian Bayraktar, Emine Ivan, Cristina Aslan, Burcu Mai, Junhua He, Guangan Mangala, Lingegowda S. Jiang, Dahai Nagaraja, Archana S. Ozpolat, Bulent Chavez-Reyes, Arturo Ferrari, Mauro Mitra, Rahul Siddik, Zahid H. Shen, Haifa Yang, Xianbin Sood, Anil K. Lopez-Berestein, Gabriel |
| author_sort | Rodriguez-Aguayo, Cristian |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9340498 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93404982022-08-02 Corrigendum to “PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis” [EBioMedicine 40 (2019) 290-304] Rodriguez-Aguayo, Cristian Bayraktar, Emine Ivan, Cristina Aslan, Burcu Mai, Junhua He, Guangan Mangala, Lingegowda S. Jiang, Dahai Nagaraja, Archana S. Ozpolat, Bulent Chavez-Reyes, Arturo Ferrari, Mauro Mitra, Rahul Siddik, Zahid H. Shen, Haifa Yang, Xianbin Sood, Anil K. Lopez-Berestein, Gabriel eBioMedicine Corrigendum Elsevier 2022-07-29 /pmc/articles/PMC9340498/ /pubmed/35914489 http://dx.doi.org/10.1016/j.ebiom.2022.104194 Text en © 2022 Published by Elsevier B.V. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Corrigendum Rodriguez-Aguayo, Cristian Bayraktar, Emine Ivan, Cristina Aslan, Burcu Mai, Junhua He, Guangan Mangala, Lingegowda S. Jiang, Dahai Nagaraja, Archana S. Ozpolat, Bulent Chavez-Reyes, Arturo Ferrari, Mauro Mitra, Rahul Siddik, Zahid H. Shen, Haifa Yang, Xianbin Sood, Anil K. Lopez-Berestein, Gabriel Corrigendum to “PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis” [EBioMedicine 40 (2019) 290-304] |
| title | Corrigendum to “PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis” [EBioMedicine 40 (2019) 290-304] |
| title_full | Corrigendum to “PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis” [EBioMedicine 40 (2019) 290-304] |
| title_fullStr | Corrigendum to “PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis” [EBioMedicine 40 (2019) 290-304] |
| title_full_unstemmed | Corrigendum to “PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis” [EBioMedicine 40 (2019) 290-304] |
| title_short | Corrigendum to “PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis” [EBioMedicine 40 (2019) 290-304] |
| title_sort | corrigendum to “ptger3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation ras-mapk/erk-ets1-elk1/cftr1 axis” [ebiomedicine 40 (2019) 290-304] |
| topic | Corrigendum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340498/ https://www.ncbi.nlm.nih.gov/pubmed/35914489 http://dx.doi.org/10.1016/j.ebiom.2022.104194 |
| work_keys_str_mv | AT rodriguezaguayocristian corrigendumtoptger3inducesovarytumorigenesisandconfersresistancetocisplatintherapythroughupregulationrasmapkerkets1elk1cftr1axisebiomedicine402019290304 AT bayraktaremine corrigendumtoptger3inducesovarytumorigenesisandconfersresistancetocisplatintherapythroughupregulationrasmapkerkets1elk1cftr1axisebiomedicine402019290304 AT ivancristina corrigendumtoptger3inducesovarytumorigenesisandconfersresistancetocisplatintherapythroughupregulationrasmapkerkets1elk1cftr1axisebiomedicine402019290304 AT aslanburcu corrigendumtoptger3inducesovarytumorigenesisandconfersresistancetocisplatintherapythroughupregulationrasmapkerkets1elk1cftr1axisebiomedicine402019290304 AT maijunhua corrigendumtoptger3inducesovarytumorigenesisandconfersresistancetocisplatintherapythroughupregulationrasmapkerkets1elk1cftr1axisebiomedicine402019290304 AT heguangan corrigendumtoptger3inducesovarytumorigenesisandconfersresistancetocisplatintherapythroughupregulationrasmapkerkets1elk1cftr1axisebiomedicine402019290304 AT mangalalingegowdas corrigendumtoptger3inducesovarytumorigenesisandconfersresistancetocisplatintherapythroughupregulationrasmapkerkets1elk1cftr1axisebiomedicine402019290304 AT jiangdahai corrigendumtoptger3inducesovarytumorigenesisandconfersresistancetocisplatintherapythroughupregulationrasmapkerkets1elk1cftr1axisebiomedicine402019290304 AT nagarajaarchanas corrigendumtoptger3inducesovarytumorigenesisandconfersresistancetocisplatintherapythroughupregulationrasmapkerkets1elk1cftr1axisebiomedicine402019290304 AT ozpolatbulent corrigendumtoptger3inducesovarytumorigenesisandconfersresistancetocisplatintherapythroughupregulationrasmapkerkets1elk1cftr1axisebiomedicine402019290304 AT chavezreyesarturo corrigendumtoptger3inducesovarytumorigenesisandconfersresistancetocisplatintherapythroughupregulationrasmapkerkets1elk1cftr1axisebiomedicine402019290304 AT ferrarimauro corrigendumtoptger3inducesovarytumorigenesisandconfersresistancetocisplatintherapythroughupregulationrasmapkerkets1elk1cftr1axisebiomedicine402019290304 AT mitrarahul corrigendumtoptger3inducesovarytumorigenesisandconfersresistancetocisplatintherapythroughupregulationrasmapkerkets1elk1cftr1axisebiomedicine402019290304 AT siddikzahidh corrigendumtoptger3inducesovarytumorigenesisandconfersresistancetocisplatintherapythroughupregulationrasmapkerkets1elk1cftr1axisebiomedicine402019290304 AT shenhaifa corrigendumtoptger3inducesovarytumorigenesisandconfersresistancetocisplatintherapythroughupregulationrasmapkerkets1elk1cftr1axisebiomedicine402019290304 AT yangxianbin corrigendumtoptger3inducesovarytumorigenesisandconfersresistancetocisplatintherapythroughupregulationrasmapkerkets1elk1cftr1axisebiomedicine402019290304 AT soodanilk corrigendumtoptger3inducesovarytumorigenesisandconfersresistancetocisplatintherapythroughupregulationrasmapkerkets1elk1cftr1axisebiomedicine402019290304 AT lopezberesteingabriel corrigendumtoptger3inducesovarytumorigenesisandconfersresistancetocisplatintherapythroughupregulationrasmapkerkets1elk1cftr1axisebiomedicine402019290304 |